Jiangsu Zecen Biotechnology Co., Ltd. is an IVD systems provider with fully automatic chemiluminescence immunoassay (CLIA) solutions as its core product. Zecen specializes in R&D, manufacturing and sales of in vitro diagnostic kits and instruments. Zecen's core products are chemiluminescent immunoassays (CLIA), with a special focus on point-of-care testing (POCT), supplemented by clinical chemistry assays.
Zecen is committed to innovation, promoting the development of precision medicine, and possesses intellectual property rights related to intelligent diagnostic systems for the chemiluminescence immunoassays, including a number of invention patents, registered trademarks, and Class III, CLASS II medical device registration certificate. R&D and production sites are located in Beijing, Shandong Weifang, Jiangsu Taizhou.
Zecen provides products and services to hospitals, CDCs, medical examination centers and other laboratories. In China, Zecen works with numerous Class II and Class III hospitals on providing quality services to the public. Internationally, Zecen not only covers markets in South-Central Asia, Latin America, Eastern Europe, Southern Europe, but has also established collaborative relationships with foreign enterprises in these regions.
“Transforming Lives with Technology” is our motto. Zecen is committed to becoming the most respected Chinese brand in the health industry.